Similar articles

• [Treatment of adult patients with aplastic anemia in Japan].

  Urabe A, Ichiki S, Usukine K, Ijima K. Urabe A, et al. Rinsho Ketsueki. 2005 Jun;46(6):389-93. Rinsho Ketsueki. 2005. PMID: 16447719 Review. Japanese. No abstract available.
• [Treatment of acquired a plastic anemia: an update].

  Kojima S. Kojima S. Rinsho Ketsueki. 2004 Mar;45(3):202-8. Rinsho Ketsueki. 2004. PMID: 15103933 Review. Japanese. No abstract available.
• [Treatment of acquired severe aplastic anemia in pediatric patients with immunosuppression and allogeneic stem cell hematopoietic transplant].

  Barriga C F, Wietstruck P A, Becker K A, Zúñiga C P, Besa De C P, Alvarez Z M, Ocqueteau T M, Bertín C P. Barriga C F, et al. Rev Med Chil. 2007 Nov;135(11):1421-8. Epub 2008 Jan 16. Rev Med Chil. 2007. PMID: 18259653 Spanish.
• Immunosuppression with ALG and CsA is first line treatment in children with SAA lacking an HLA identical sibling.

  Békássy AN, Locasciulli A, Marsh JC, Socié G, Fuehrer M, Passweg J. Békássy AN, et al. Pediatr Blood Cancer. 2005 Sep;45(3):359-60; author reply 361-2. doi: 10.1002/pbc.20418. Pediatr Blood Cancer. 2005. PMID: 15940724 No abstract available.
• Management of aplastic anemia after failure of frontline immunosuppression.

  Pierri F, Dufour C. Pierri F, et al. Expert Rev Hematol. 2019 Oct;12(10):809-819. doi: 10.1080/17474086.2019.1645003. Epub 2019 Jul 24. Expert Rev Hematol. 2019. PMID: 31311355 Review.